MicrosoftLive sourceEvidence: Medium60/100

Syneos Health optimizes clinical trials and biopharma performance

Syneos Health has formed a multi-year strategic partnership with Microsoft to enhance clinical trials and commercial processes for biopharma clients. Utilizing the Microsoft Azure platform, including services such as Azure Synapse Analytics, Data Factory, and SQL Database, and incorporating advancements from OpenAI, Syneos developed an AI-enabled analytics platform aimed at streamlining site selection, reducing enrollment timelines, and accelerating treatment delivery. This collaboration combines Microsoft's AI leadership and Syneos Health's biopharma expertise to deliver critical advancements in health sciences.

Organization
Syneos Health
Industry
Healthcare
Published
March 2023

Reported outcomes

Strategic outcomes

Ecosystem & partnershipsFormed a multi-year strategic partnershipNew product / capabilityDeveloped an AI-enabled analytics platformSpeed & agilityStreamlined site selection and decision-makingCustomer experience & trustAccelerated treatment delivery to patients
Why do we believe this deployment?Customer identity, provider attribution, maturity, and source checks
Customer
Syneos Health
Provider
Microsoft
Maturity
Unknown
Linked source
Contract Pharma

No explicit deployment-stage evidence found.

Customer identity supportedSource describes one deploymentMaturity evidence evaluated

Primary read

Use case focus

Showing 3 of 3

  • 1Clinical trial optimization
  • 2Machine learning-driven analytics
  • 3Accelerated treatment delivery
  • Lengthy clinical trial enrollment processes.
  • Inefficient resource allocation during trial execution.
  • Delayed delivery of new treatments to patients.
  • Need to improve data processing and analysis in biopharma.
  • Developed an AI-enabled platform using Microsoft Azure services.
  • Integrated Azure Synapse Analytics, Azure Data Factory, and Azure SQL Database.
  • Collaborated with Microsoft Research and incorporated OpenAI's developments.
  • Enhanced data processing and machine learning capabilities to fast-track decision-making.
  • Reduced clinical trial enrollment timelines.
  • Optimized resource allocation during trials.
  • Accelerated delivery of therapies to patients.
  • Improved overall efficiency in clinical development.
Architecture

The analytics platform integrates Azure Synapse Analytics for data analysis, Azure Data Factory for data processing, and Azure SQL Database for structured data storage. Machine learning models analyze clinical trial data to optimize site selection and resource allocation.

Sources & evidence2
Evidence: Medium60/100Evidence strength
  • Customer explicitly identified
  • Independent source available
  • Technical implementation details available
  • Multiple corroborating sources available
  • Recent evidence check available
  • Last evidence check: Jul 22, 2026.
Live sourceStill referenced

The case's original source is still reachable.

  • Cited source last checked Jun 12, 2026 — ok (0/2 broken).

Measures whether this deployment's public evidence persists — not whether the system is still in production.

Type: News ArticlePublished: Mar 20, 2023Publisher: Contract PharmaEvidence: SecondaryConfidence: Low

AI-generated summary. Verify important details with the linked sources before relying on this case.

Explore related AI use cases

Was this useful?

Community

Comments

No published comments yet.